Data as of May 22
| -0.10 / -1.08%|
The 20 analysts offering 12-month price forecasts for Boston Scientific Corp have a median target of 8.00, with a high estimate of 12.00 and a low estimate of 6.50. The median estimate represents a -12.38% decrease from the last price of 9.13.
The current consensus among 26 polled investment analysts is to Hold stock in Boston Scientific Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.